mitomycin has been researched along with Epidermolysis Bullosa in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Epidermolysis Bullosa: Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palinko, D | 1 |
| Matievics, V | 1 |
| Szegesdi, I | 1 |
| Sztano, B | 1 |
| Rovo, L | 1 |
1 other study available for mitomycin and Epidermolysis Bullosa
| Article | Year |
|---|---|
Minimally invasive endoscopic treatment for pediatric combined high grade stenosis as a laryngeal manifestation of epidermolysis bullosa.
Topics: Alkylating Agents; Arytenoid Cartilage; Cautery; Child, Preschool; Epidermolysis Bullosa; Female; Hu | 2017 |